title: [Therapy of malignant melanoma with beta-interferons].
abstract: Since June, 1985, we have been treating 18 evaluable patients suffering from high risk melanoma with human beta-interferon (HBIF), 10 of the patients received HBIF infusions, 8 patients got subcutaneous injections into the regional lymph nodes. In some of the cases, this treatment resulted in obviously prolonged survival times; at present, however, the effect of HBIF is still beyond calculation.
authors.affiliation: Dermatologische Klinik, Universität Würzburg.
authors.forename: G
authors.initials: G
authors.lastname: Faulhaber
authors.forename: W
authors.initials: W
authors.lastname: Lechner
authors.forename: H
authors.initials: H
authors.lastname: Röckl
mesh_terms: D003131:Combined Modality Therapy; D006801:Humans; D007262:Infusions, Intravenous; D007279:Injections, Subcutaneous; D007370:Interferon Type I / Q000627:therapeutic use*; D008197:Lymph Node Excision; D008545:Melanoma / Q000601:surgery / Q000628:therapy*; D012878:Skin Neoplasms / Q000601:surgery / Q000628:therapy*
chemical_list: D007370:Interferon Type I
vernacular_title: Therapie des malignen Melanoms mit beta-Interferonen.